FrancophonIA/ELRC3.0 huggingface dataset:
English: Tumour size 2 cm >2 cm
Croatian: Veličina tumora ≤2 cm >2 cm
English: A final analysis was performed with an actual median follow-up of 96 months.
Croatian: Konačna analiza provedena je sa stvarnim medijanom praćenja od 96 mjeseci.
English: Based on a population pharmacokinetic analysis, there are no special instructions for use in the older people.
Croatian: Na temelju populacijske farmakokinetičke analize, nema posebnih uputa za primjenu u starijih osoba.
English: ER = oestrogen receptor
Croatian: ER = estrogenski receptor
English: The marketing authorisation holder shall submit PSUR for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal.
Croatian: Nositelj odobrenja će podnositi PSUR za ovaj lijek u skladu s referentnim popisom datuma EU (EURD popis) predviđenim člankom 107(c) stavkom 7 Direktive 2001/83/EZ i objavljenim na europskom internetskom portalu za lijekove.
English: This includes any possible side effect not listed in this leaflet.
Croatian: To uključuje i svaku moguću nuspojavu koja nije navedena u ovoj uputi.
English: The safety and efficacy of Docetaxel Zentiva in nasopharyngeal carcinoma in children aged 1 month to less than 18 years have not yet been established.
Croatian: Sigurnost primjene i djelotvornost lijeka Docetaxel Zentiva u nazofaringealnom karcinomu u djece starosti od 1 mjeseca do 18 godina nije još ustanovljena.
English: Date of last renewal: 20 April 2012
Croatian: Datum posljednje obnove odobrenja: 20. travnja 2012.
English: What Docetaxel Zentiva is and what it is used for
Croatian: Što je Docetaxel Zentiva i za što se koristi
English: Your doctor may change the dose and frequency of dosing depending on your blood tests, your general condition and your response to Docetaxel Zentiva.
Croatian: Vaš liječnik može mijenjati dozu i učestalost primjene lijeka ovisno o rezultatima krvnih pretraga, Vašem općem stanju i terapijskom odgovoru na Docetaxel Zentiva.
English: permanent hair loss has been observed
Croatian: (nepoznata učestalost) primijećen je trajan gubitak kose
English: It is important that you read the entire contents of this guide prior to the preparation of the Docetaxel Zentiva infusion solution.
Croatian: Važno je pročitati cijeli sadržaj upute prije pripreme Docetaxel Zentiva infuzijske otopine.
English: 95% CI p-valuea* a Time to event variables: Stratified log-rank test.
Croatian: 95% CI p-vrijednosta* a Varijable vremena do događaja: Stratificirani log-rang test.
English: • raised liver enzymes (hence the need for regular blood tests)
Croatian: • povišeni jetreni enzimi (potrebne redovite krvne pretrage)
English: Progressive disease as best overall response (%) *Unstratified log rank test
Croatian: Progresija bolesti kao najbolji ukupni odgovor (%) * nestratificirani log-rank test
English: Before each treatment with Docetaxel Zentiva, you will have blood tests to check that you have enough blood cells and sufficient liver function to receive Docetaxel Zentiva.
Croatian: Prije svake primjene Docetaxel Zentiva, obavit ćete krvne pretrage kako bi se provjerilo imate li dovoljno krvnih stanica te odgovarajuću funkciju jetre kako biste mogli primiti Docetaxel Zentiva.
English: How to store Docetaxel Zentiva Contents of the pack and other information
Croatian: Kako čuvati Docetaxel Zentiva Sadržaj pakiranja i druge informacije
English: You must not become pregnant during treatment with this medicine and must use an effective method of contraception during therapy, because Docetaxel Zentiva may be harmful for the unborn baby.
Croatian: Ne smijete zatrudnjeti tijekom uzimanja ovog lijeka i morate provoditi učinkovite mjere kontracepcije tijekom liječenja, jer Docetaxel Zentiva može biti štetan za nerođeno dijete.
English: Secondary end-points included change of pain, global rating of quality of life by EuroQoL-5D, Lung Cancer Symptom Scale, and changes in Karnofsky performance status.
Croatian: Sekundarni ishodi uključivali su promjenu u stupnju boli, opću procjenu kvalitete života prema EuroQoL-5D, ljestvici simptoma karcinoma pluća (Lung Cancer Symptom Scale) i promjene u Karnofski izvedbenom statusu.
English: PR = progesterone receptor a ER/PR-negative or Grade 3 or tumour size >5 cm
Croatian: PR = progesteronski receptor a ER/PR-negativni ili gradus 3 ili veličina tumora >5 cm
English: Docetaxel Zentiva will be given by infusion into one of your veins (intravenous use).
Croatian: Docetaxel Zentiva ćete dobiti infuzijom u jednu od vena (intravenska primjena).
English: Sanofi-Aventis Deutschland GmbH Industriepark Höchst 65926 Frankfurt am Main Germany
Croatian: Sanofi-Aventis Deutschland GmbH Industriepark Höchst 65926 Frankfurt na Majni Njemačka
English: See accompanying preparation guide.
Croatian: Vidjeti priložene upute za pripremu lijeka.
English: Docetaxel Zentiva contains alcohol.
Croatian: Docetaxel Zentiva sadrži alkohol.
English: OTHER SPECIAL WARNING(S), IF NECESSARY CYTOTOXIC
Croatian: DRUGO(A) POSEBNO(A) UPOZORENJE(A), AKO JE POTREBNO CITOTOKSIČNO
English: What Docetaxel Zentiva is and what it is used for What you need to know before you use Docetaxel Zentiva How to use Docetaxel Zentiva Possible side effects
Croatian: Što je Docetaxel Zentiva i za što se koristi Što morate znati prije nego počnete primati Docetaxel Zentiva Kako primjenjivati Docetaxel Zentiva Moguće nuspojave
English: In the case of severe neutropenia (< 500 cells/mm3 for seven days or more) during a course of docetaxel therapy, a reduction in dose for subsequent courses of therapy or the use of appropriate symptomatic measures are recommended (see section 4.2).
Croatian: U slučajevima teške neutropenije (< 500 stanica/mm u trajanju od sedam dana ili dulje) za vrijeme liječenja docetakselom, preporuča se smanjenje doze u sljedećim ciklusima liječenja ili primjena odgovarajućih simptomatskih mjera (vidjeti dio 4.2).
English: If signs and symptoms suggestive of these reactions appear, discontinuation of docetaxel should be considered.
Croatian: Ako se pojave znakovi ili simptomi koji ukazuju na takve reakcije, potrebno je razmotriti prekid terapije docetakselom.
English: In patients who were 75 years of age or older, when compared to younger patients, neutropenia, anemia, diarrhea, dyspnea and upper respiratory tract infection were reported with a greater incidence (at least 10% higher).
Croatian: U bolesnika koji su bili u dobi od 75 godina ili stariji, u usporedbi s mlađim bolesnicima, neutropenija, anemija, proljev, dispneja i infekcije gornjih dišnih puteva prijavljivane su s višom incidencijom (najmanje 10% višom).
English: What Docetaxel Zentiva contains - The active substance is docetaxel (as trihydrate).
Croatian: Što Docetaxel Zentiva sadrži - Djelatna tvar je docetaksel (u obliku docetaksel trihidrata).
English: What you need to know before you use Docetaxel Zentiva
Croatian: Što morate znati prije nego počnete primati Docetaxel Zentiva
English: Docetaxel Zentiva must NOT be administered if you are pregnant unless clearly indicated by your doctor.
Croatian: Docetaxel Zentiva NE SMIJETE primati ako ste trudni, osim ako to liječnik nije izričito propisao.
English: Between infusions of Docetaxel Zentiva the following may occur, and the frequency may vary with the combinations of medicines that are received:
Croatian: Između infuzija Docetaxel Zentiva mogu se pojaviti sljedeće nuspojave, a učestalost može varirati ovisno o kombinacijama lijekova koje ste primili:
English: The incidence of serious adverse events was higher in the older people compared to younger patients.
Croatian: Incidencija ozbiljnih nuspojava bila je veća u starijih osoba u odnosu na mlađe bolesnike.
English: Docetaxel Zentiva was administered as a 1-hour infusion, all other medicinal products were given intravenously on day 1 every three weeks.
Croatian: Docetaxel Zentiva se primjenjivao u obliku jednosatne infuzije, a svi ostali lijekovi davali su se intravenski na dan 1 svaka tri tjedna.
English: You will be asked to take premedication consisting of an oral corticosteroid such as dexamethasone, one day prior to Docetaxel Zentiva administration and to continue for one or two days after it in order to minimise certain undesirable effects which may occur after the infusion of Docetaxel Zentiva in particular allergic reactions and fluid retention (swelling of the hands, feet, legs or weight gain).
Croatian: Od Vas će se tražiti da uzmete premedikaciju koja se sastoji od oralnih kortikosteroida, poput deksametazona, dan prije primjene Docetaxel Zentiva te još dan ili dva nakon toga, kako bi se smanjile određene nuspojave, koje se mogu pojaviti nakon infuzije Docetaxel Zentiva, osobito alergijske reakcije i zadržavanje tekućine u tijelu (oticanje ruku, stopala, nogu ili povećanje tjelesne težine).
English: There was less use of morphinic analgesic (p < 0.01), non-morphinic analgesics (p < 0.01), other disease-related medicinal products (p = 0.06) and radiotherapy (p < 0.01) in patients treated with docetaxel at 75 mg/m² compared to those with BSC.
Croatian: Manje su se davali morfinski analgetici (p<0,01), nemorfinski analgetici (p<0,01), ostali lijekovi povezani s bolesti (p=0,06) i radioterapija (p<0,01) bolesnicima koji su se liječili docetakselom 75 mg/m nego onima iz skupine BSC.
English: Other medicines and Docetaxel Zentiva
Croatian: Drugi lijekovi i Docetaxel Zentiva
English: Docetaxel Zentiva will be administered to you by a healthcare professional.
Croatian: Docetaxel Zentiva će Vam davati zdravstveni djelatnik.
English: If the vials are stored under refrigeration, allow the required number of boxes of Docetaxel Zentiva concentrate for solution for infusion to stand below 25°C for 5 minutes before use.
Croatian: Ako su bočice pohranjene u hladnjaku, izvadite potreban broj kutija Docetaxel Zentiva koncentrata za otopinu za infuziju iz hladnjaka i ostavite ih na temperaturi ispod 25°C 5 minuta prije primjene.
English: See also section “Docetaxel Zentiva contains ethanol (alcohol)” below.
Croatian: Pogledajte također dio "Docetaxel Zentiva sadrži etanol (alkohol)" dalje u tekstu.
English: TAC = docetaxel, doxorubicin and cyclophosphamide FAC = 5-fluorouracil, doxorubicin and cyclophosphamide CI = confidence interval; ER = oestrogen receptor PR = progesterone receptor a ER/PR-negative or Grade 3 or tumour size >5 cm
Croatian: TAC = docetaksel, doksorubicin i ciklofosfamid FAC = 5-fluorouracil, doksorubicin i ciklofosfamid CI = interval pouzdanosti; ER = estrogenski receptor PR = progesteronski receptor a ER/PR-negativni ili gradus 3 ili veličina tumora >5 cm
English: Docetaxel plus trastuzumab1 n = 92
Croatian: Docetaksel + trastuzumab n=92
English: Mean values for total body clearance and steady-state volume of distribution were 21 l/h/m2 and 113 l, respectively.
Croatian: Srednje vrijednosti ukupnog klirensa i volumena distribucije u stanju dinamičke ravnoteže bile su 21 l/h/m2, odnosno 113 l.
English: More patients aged ≥65 years in the docetaxel arm reported hypersensitivity reaction, neutropenia, anemia, fluid retention, dyspnea, and nail changes when compared to the patients aged less than 65 years.
Croatian: Više bolesnika u dobi od ≥ 65 godina u skupini koja je primala docetaksel prijavilo je reakcije preosjetljivosti, neutropeniju, anemiju, retenciju tekućine, dispneju i promjene na noktima u usporedbi s bolesnicima u dobi mlađoj od 65 godina.
English: • if you are allergic (hypersensitive) to docetaxel or any of the other ingredients of Docetaxel
Croatian: • ako ste alergični (preosjetljivi) na docetaksel ili neki drugi sastojak Docetaxel Zentiva (naveden u dijelu 6).
English: The most commonly reported adverse reactions of Docetaxel Zentiva alone are: decrease in the number of red blood cells or white blood cells, alopecia, nausea, vomiting, sores in the mouth, diarrhoea and tiredness.
Croatian: Najčešće prijavljivane nuspojave Docetaxel Zentiva kada se primjenjuje sam su: pad broja crvenih ili bijelih krvnih stanica, gubitak kose, mučnina, povraćanje, ranice u ustima, proljev i umor.
English: TAC = docetaxel, doxorubicin and cyclophosphamide FAC = 5-fluorouracil, doxorubicin and cyclophosphamide CI = confidence interval
Croatian: TAC = docetaksel, doksorubicin i ciklofosfamid FAC = 5-fluorouracil, doksorubicin i ciklofosfamid CI = interval pouzdanosti;
English: România S.C. ZENTIVA S.A.
Croatian: S.C. ZENTIVA S.A.
English: Hypersensitivity reactions (frequency not known) have been reported with docetaxel in patients who previously experienced hypersensitivity reactions to paclitaxel.
Croatian: Reakcije preosjetljivosti (učestalost nije poznata) prijavljene su za docetaksel u bolesnika koji su prethodno doživjeli reakcije preosjetljivosti na paklitaksel.
English: What Docetaxel Zentiva looks like and contents of the pack Docetaxel Zentiva concentrate for solution for infusion is a pale yellow to brownish-yellow solution.
Croatian: Kako Docetaxel Zentiva izgleda i sadržaj pakiranja Docetaxel Zentiva koncentrat za otopinu za infuziju je blijedo žuta do smeđežuta otopina.
English: Median duration of response to chemotherapy  radiotherapy (months) (95% CI)
Croatian: Medijan trajanja odgovora na kemoterapiju ± radioterapiju (mjeseci) (95% CI)
English: Docetaxel Zentiva contains ethanol (alcohol)
Croatian: Docetaxel Zentiva sadrži etanol (alkohol)
English: The name of this medicine is Docetaxel Zentiva.
Croatian: Ovaj lijek se zove Docetaxel Zentiva.
English: Disease-free survival (DFS) was the primary efficacy endpoint and overall survival (OS) was the secondary efficacy endpoint.
Croatian: Preživljenje bez znakova bolesti (DFS) bio je primarni ishod djelotvornosti, a ukupno preživljenje (OS) sekundarni ishod djelotvornosti.
English: Docetaxel Zentiva has been prescribed by your doctor for the treatment of breast cancer, special forms of lung cancer (non-small cell lung cancer), prostate cancer, gastric cancer or head and neck cancer: - For the treatment of advanced breast cancer, Docetaxel Zentiva could be administered either alone or in combination with doxorubicin, or trastuzumab, or capecitabine.
Croatian: Docetaxel Zentiva Vam je propisao liječnik za liječenje karcinoma dojke, posebnih oblika karcinoma pluća (karcinom nemalih stanica pluća), karcinoma prostate, karcinoma želuca ili karcinoma glave i vrata: - Za liječenje uznapredovalog karcinoma dojke, Docetaxel Zentiva se primjenjuje sam ili u kombinaciji s doksorubicinom, trastuzumabom ili kapecitabinom.
English: Tumour response rate (%) 95% CI p-value* †Stratified log rank test *Threshold for statistical significance = 0.0175 **PSA: Prostate-Specific Antigen
Croatian: Stratificirani log- rank test * prag statističke značajnosti = 0,0175 ** PSA: prostata specifični antigen
English: The incidence of the following adverse events (all grades): lethargy, stomatitis, neutropenic infection occurred at rates  10% higher in patients who were 65 years of age or older compared to younger patients.
Croatian: Incidencija sljedećih nuspojava (svi stupnjevi): letargija, stomatitis, neutropenijska infekcija bila je ≥10% viša u bolesnika koji su imali 65 ili više godina u odnosu na mlađe bolesnike.
English: You must not be given Docetaxel Zentiva:
Croatian: Docetaxel Zentiva se ne smije primijeniti:
English: Marketing Authorisation Holder Zentiva k.s.
Croatian: Nositelj odobrenja za stavljanje lijeka u promet Zentiva k.s.,
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 20 April 2007
Croatian: Datum prvog odobrenja: 20. travnja 2007.
English: Following the administration of a 100 mg/m2 dose given as a one-hour infusion a mean peak plasma level of 3.7 µg/ml was obtained with a corresponding AUC of 4.6 h.µg/ml.
Croatian: Nakon primjene doze od 100 mg/m putem jednosatne infuzije, dobivena je srednja vrijednost vršne razine lijeka u plazmi od 3,7 μg/ml s odgovarajućim AUC-om od 4,6 h μg/ml.
English: If you are a man being treated with Docetaxel Zentiva you are advised not to father a child during and up to 6 months after treatment and to seek advice on conservation of sperm prior to treatment because docetaxel may alter male fertility.
Croatian: Muškarcima koji primaju Docetaxel Zentiva savjetuje se da ne začinju dijete tijekom liječenja i do 6 mjeseci nakon prestanka terapije te da potraže savjet o konzervaciji sperme prije liječenja, jer docetaksel može utjecati na plodnost muškarca.
English: As with all parenteral products, Docetaxel Zentiva infusion solution should be visually inspected prior to use, solutions containing a precipitate should be discarded.
Croatian: Kao što je slučaj sa svim parenterainim pripravcima, Docetaxel Zentiva otopina za infuziju mora se vizualno provjeriti prije primjene, a otopine koje sadrže precipitat ne smiju se koristiti.
English: Do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i naljepnici bočice iza 'Rok valjanosti/EXP'.
English: This is because Docetaxel Zentiva or the other medicine may not work as well as expected and you may be more likely to get a side effect.
Croatian: Naime, može se dogoditi da u tom slučaju Docetaxel Zentiva ili neki drugi lijek neće djelovati prema očekivanju te da postoji veća vjerojatnost pojave nuspojava.
English: You may also have flu-like symptoms at the same time, such as fever, chills or aching muscles.)
Croatian: Također istovremeno možete imati simptome nalik gripi, poput vrućice, zimice ili bolnih mišića.)
English: In patients treated with docetaxel at 100 mg/m2 as single agent who have serum transaminase levels (ALT and/or AST) greater than 1.5 times the ULN concurrent with serum alkaline phosphatase levels greater than 2.5 times the ULN, there is a higher risk of developing severe adverse reactions such as toxic deaths including sepsis and gastrointestinal haemorrhage which can be fatal, febrile neutropenia, infections, thrombocytopenia, stomatitis and asthenia.
Croatian: U bolesnika koji su primali docetaksel u dozi od 100 mg/m kao jedinu terapiju te imali vrijednosti transaminaza (ALT i/ili AST) u serumu više od 1,5 puta veće od GGN, te serumsku alkalnu fosfatazu više od 2,5 puta veću od GGN, postoji viši rizik od razvoja teških nuspojava poput toksične smrti uključujući sepsu i gastrointestinalno krvarenje koje može biti fatalno, febrilne neutropenije, infekcije, trombocitopenije, stomatitisa i astenije.
English: Docetaxel1 n = 94
Croatian: Docetaksel n=94
English: Patients who experience Grade 3 or 4 stomatitis should have their dose decreased to 60 mg/m².
Croatian: Bolesnicima u kojih se pojavi stomatitis stupnja 3 ili 4 treba smanjiti dozu na 60 mg/m
English: The most frequently reported symptoms were flushing, rash with or without pruritus, chest tightness, back pain, dyspnoea and fever or chills.
Croatian: Najčešće zabilježeni simptomi bili su naleti vrućine, osip sa/bez svrbeža, stezanje u prsima, bol u leđima, dispneja, vrućica ili zimica.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of concentrate contains 20 mg docetaxel (as trihydrate).
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV l ml koncentrata sadržava 20 mg docetaksela (u obliku docetaksel trihidrata).
English: • decrease of the sodium and/or magnesium in your blood (electrolyte balance disorders)
Croatian: • smanjena razina natrija, i/ili magnezija u krvi (poremećaji ravnoteže elektrolita).
English: The required volume of Docetaxel Zentiva concentrate for solution for infusion must be injected via a single injection (one shot) into a 250 ml infusion bag or bottle containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
Croatian: Potrebni volumen Docetaxel Zentiva koncentrata za otopinu za infuziju mora se injicirati jednokratnom injekcijom (jedno injiciranje) u infuzijsku vrećicu ili bocu od 250 ml koja sadrži ili 5%tnu otopinu glukoze ili 0,9%-tnu (9 mg/ml) otopinu natrijevog klorida.
English: Metastatic hormone-sensitive prostate cancer STAMPEDE study
Croatian: Metastatski karcinom prostate osjetljiv na hormone STAMPEDE studija
English: Docetaxel Zentiva in combination with androgen-deprivation therapy (ADT), with or without prednisone or prednisolone, is indicated for the treatment of patients with metastatic hormonesensitive prostate cancer.
Croatian: Docetaxel Zentiva u kombinaciji s terapijom deprivacije androgena (engl. androgen deprivation therapy, ADT), s ili bez prednizona ili prednizolona, indiciran je za liječenje bolesnika s metastatskim karcinomom prostate osjetljivim na hormone.
English: c The time to clinical progression = the time from randomization until clinical progression (i.e., increased symptoms of bone metastases; progression according to RECIST; or clinical deterioration due to cancer according to the investigator's opinion).
Croatian: = vrijeme od randomizacije do kliničke progresije bolesti (tj. povećani simptomi metastaza u kostima; progresija prema RECIST kriterijima; ili pogoršanje kliničke slike zbog raka prema mišljenju ispitivača)
English: There is no relevant use of Docetaxel Zentiva in the paediatric population in the indications breast cancer, non-small cell lung cancer, prostate cancer, gastric carcinoma and head and neck cancer, not including type II and III less differentiated nasopharyngeal carcinoma.
Croatian: Nema relevantne primjene lijeka Docetaxel Zentiva u pedijatrijskoj populaciji za indikacije karcinoma dojke, karcinoma nemalih stanica pluća, karcinoma prostate, karcinoma želuca i karcinoma glave i vrata, ne uključujući manje diferencirani nazofaringealni karcinom tipa II i III.
English: As the benefit observed in patient with 4+ nodes was not statistically significant on disease-free survival (DFS) and overall survival (OS), the positive benefit/risk ratio for TAC in patients with 4+ nodes was not fully demontrated at the final analysis (see section 5.1).
Croatian: S obzirom na to da korist liječenja uočena u bolesnika s 4 i više pozitivnih limfnih čvorova nije bila statistički značajna u pogledu preživljenja bez znakova bolesti (DFS) i ukupnog preživljenja (OS), pozitivan omjer koristi i rizika TAC protokola u bolesnika s 4 i više pozitivnih limfnih čvorova nije potpuno dokazan u konačnoj analizi rezultata (vidjeti dio 5.1).
English: The severity of adverse events of Docetaxel Zentiva may be increased when Docetaxel Zentiva is given in combination with other chemotherapeutic agents.
Croatian: Težina nuspojava Docetaxel Zentiva može se povećati kada se daje u kombinaciji s drugim kemoterapeuticima.
English: Patients with baseline neutrophil count of < 1,500 cells/mm3.
Croatian: Bolesnici s početnim brojem neutrofila < 1500 stanica/mm
English: Infusion site reaction; Non-cardiac chest pain (severe: 0.4%)
Croatian: bol reakcija na mjestu primjene infuzije; bol u prsima nekardiološke etiologije (teška: 0,4%)
English: • 1312 and 121 patients who received 100 mg/m² and 75 mg/m² of docetaxel as a single agent respectively.
Croatian: • 1312 bolesnika koji su primali 100 mg/m i 121 bolesnika koji su primali 75 mg/m docetaksela kao monoterapiju,
English: Zentiva k.s., U kabelovny 130, 102 37 Prague 10, Czech Republic
Croatian: Zentiva k.s., U kabelovny 130, 102 37 Prague 10, Češka Republika
English: In combination with capecitabine, the recommended dose of docetaxel is 75 mg/m2 every three weeks, combined with capecitabine at 1250 mg/m2 twice daily (within 30 minutes after a meal) for 2 weeks followed by a 1-week rest period.
Croatian: U kombinaciji s kapecitabinom, preporučena doza docetaksela je 75 mg/m svaka tri tjedna u kombinaciji s kapecitabinom u dozi od 1250 mg/m dvaput dnevno (unutar pola sata nakon obroka) u trajanju od 2 tjedna, nakon čega slijedi tjedan dana pauze.